HealthcareLisata jumps on FDA orphan drug status for liver cancer drugBy Helitra.com·September 7, 2024·1 min read Lisata jumps on FDA orphan drug status for liver cancer drug Source: SeekingalphaADVERTISEMENT ADVERTISEMENTcancer drug FDA jumps Lisata liver orphan status Post navigation Previous storyAscendis raised to outperform by Oppenheimer ahead of drug launchNext storyEli Lilly bets $409M for AI-focused drug discovery
Fitness · HealthcareParents Are Declining the Newborn Vitamin K Shot. What Does It Actually Do?November 17, 2026Infant bleeding is on the rise, and it has to do with the vitamin K shot. The hard numbers are shocking: as rates…
Fitness · HealthcareExpert: These Are the Most Common Dental Emergencies During the HolidaysNovember 17, 2026Every year, an estimated 2 million Americans visit the emergency room for dental pain, according to the American Dental Association (ADA). Add to…
Fitness · HealthcareThese are the 6 worst shoes for walking, according to podiatristsNovember 17, 2026I love the look of a pointed-toe high-heeled boot and the effortlessness of a ballet flat, but taking one too many steps in…